Effective October 9, 2024, the CCRA Advisory Board voted to modify the Exceptional Leadership in Cancer Research to the “Philip E. Branton Award for Exceptional Leadership in Cancer Research” to acknowledge and recognize Dr. Branton’s pivotal role in the creation of CCRA and his extraordinary contribution to Canada’s cancer research community. Dr. Branton was the inaugural recipient of this award when the program was initiated in 2011.
Dr. Branton obtained his PhD from the Ontario Cancer I... Read More »
Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s (LLSC) Operating Grant program for research aimed at preventing, detecting and treating all types of blood cancers. The application process consists of two phases. The first phase is submission and consid... Read More »